Working with pharma companies to provide access to wrap-around exercise and lifestyle support for people with CKM conditions
Our clinically-proven* platform offers access to digital exercise, diet and education programmes designed by expert physiotherapists and dietitians, which can be provided as wrap-around care alongside medications for cardio-kidney-metabolic (CKM) conditions.
With specialist solutions for a range of CKM treatment options - including GLP-1 supported weight loss, digital rehabilitation for CKM patients, and tailored content for transplantation and dialysis - we can help ensure patients are provided with condition-specific exercise, nutritional and lifestyle support in line with prescribing guidelines.
Developed in partnership with world-leading clinicians, charities and research institutions
Proven to improve health for people with CKM conditions
Beam is scientifically proven to improve physical function, mental health, ability to self-manage health, fatigue, and reduce social isolation
Trusted, physio-led digital exercise and diet programmes
Tailored programmes led by physiotherapists who are experts in CKM conditions
Our virtual classes are 88% cheaper than face-to-face services
Virtual classes that can be delivered at scale, with comparable outcomes, far more affordably than face-to-face
*Greenwood et al, 2024, The Lancet Digital Health
Helping pharma companies increase the reach of innovative CKM treatments
Over a billion people worldwide have at least one of the main CKM conditions.
Rates of cardio-kidney-metabolic conditions are rising rapidly as the population ages, increasing the need for innovative interventions. Physical inactivity and lifestyle pose a major challenge among this patient group.
While there is no cure for CKM disease, increasing physical activity and encouraging better condition management can significantly improve health, alongside medications and clinical treatment options.
Wrap-around care for GLP-1 weight management prescribing
Our wrap-around digital programmes can be provided alongside GLP-1s for people with cardio-kidney-metabolic conditions, helping to meet prescribing guidelines for the medications to be offered with exercise and dietary support.

Why should pharma companies partner with Beam?
Evidence-based, clinically proven solution
Beam has been scientifically proven in a multi-centre randomised controlled clinical trial to significantly improve health outcomes for kidney patients compared to usual care
Demonstrate prescribing in line with guidelines
Help prescribers to provide medications in line with guidelines around exercise and diet advice
CKM-specific programmes tailored for complex conditions
Created in collaboration with world-leading clinicians, therapists and researchers
Support patient engagement programmes
Provide content that goes “beyond the pill” and promotes healthy habits
Help alleviate waiting lists for access to medications
Mitigate waiting lists for face-to-face wrap-around services with our digital solution
Differentiation and corporate social responsibility
Stand out and show commitment to corporate social responsibility initiatives
Read our published evidence and case studies
As a clinically-led solution, we are proud to have several groundbreaking research studies published in multiple peer-reviewed journals, and also have a wide range of real-world implementation examples across different cardio-kidney-metabolic use cases.
Feedback from clinicians and patients

Contact us to discuss providing Beam as a wrap-around service
We would love to discuss how Beam could help provide wrap-around weight management services to supplement your product - please get in touch to find out more.